Fact CheckerSign in

NCT01169207Active, not recruiting

Johns Hopkins Crohn's Disease and Ulcerative Colitis Study

Source: ClinicalTrials.gov · Last updated 16 Jan 2026

Brief summary (registry, in English)

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This current protocol was established in 1996 with the goal of identifying the genetic and environmental components that contribute to the development of IBD, especially in families.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
2500 (estimated)
First submitted
23 Jul 2010
Start date
Jul 1996
Primary completion date
Dec 2027
Lead sponsor
Johns Hopkins University
NCT number
NCT01169207

What you commit to

  • Study type: Observational
  • Planned participants: 2500
  • From Jul 1996 to the primary completion date, Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • The only exclusions are age parameters and health reasons that would preclude enrollment; such as, for anemic patients. Blood-draws on anemic patients may, in certain medical cases, pose a health risk; therefore, the investigators request that if the participants are anemic that the participants present a letter from the participant's personal physician giving explicit permission for the participant to join if at the time it is clinically advisable.

Who the study is looking for

  • ADULTS:
  • Patients with IBD and family members who have or do not have IBD.
  • People that do not have IBD nor have a family member with IBD needed for comparison purposes.
    • CHILDREN:
  • Children age 5 or older with IBD and family members who have or do not have IBD.
  • Children that do not have IBD nor have a family member with IBD needed for comparison purposes.

Age in the registry: 5 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins University
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.